Teva Pharma (TEVA) PT Raised to $17 at Jefferies, 'Innovation Strategy Resonating'
Tweet Send to a Friend
Jefferies analyst Glen Santangelo raised the price target on Teva Pharma (NYSE: TEVA) to $17.00 (from $16.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
